How to Buy Ambalal Sarabhai Enterprises Ltd Shares?
You can easily buy the stocks/shares of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Ambalal Sarabhai Enterprises Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of AMBALALSA as on 15th May 2025 is ₹38.42What is the return on Ambalal Sarabhai Enterprises Ltd share?
The past returns of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) share are- Past 1 week: N/A
- Past 1 month: -99.07
- Past 3 months: -1.03
- Past 6 months: -43.30
- Past 1 year: -19.18
- Past 3 years: 12.40
- Past 5 years: 139.21
What is the Dividend yield % on Ambalal Sarabhai Enterprises Ltd share?
The current dividend yield of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is N/AWhat is the Market Cap of Ambalal Sarabhai Enterprises Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is ₹278.27Cr as of 15th May 2025What is the 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd?
The 52-week high and low of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is ₹77.70 and ₹34.11.What is the PE and PB ratio of Ambalal Sarabhai Enterprises Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Ambalal Sarabhai Enterprises Ltd are 56.44 and 2.03 respectively.Which sector does Ambalal Sarabhai Enterprises Ltd belong to?
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Ambalal Sarabhai Enterprises Ltd?
The peers or stocks similar to Ambalal Sarabhai Enterprises Ltd are: and many others.Can't decide whether or not to buy Ambalal Sarabhai Enterprises Ltd?
Worry no more! Login to Tickertape and check out Ambalal Sarabhai Enterprises Ltd (AMBALALSA) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd?
The 52-week high and low of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is ₹77.70 and ₹34.11.1. Test Stocks FAQ for Ambalal Sarabhai Enterprises Ltd Shares?
You can easily buy the stocks/shares of Ambalal Sarabhai Enterprises Ltd (AMBALALSA) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Ambalal Sarabhai Enterprises Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of AMBALALSA as on 15th May 2025 is ₹38.42
Ambalal Sarabhai Enterprises Ltd
AMBALALSA Share Price
38.422.64% (+0.99)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
AMBALALSA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AMBALALSA Performance & Key Metrics
AMBALALSA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 56.44 | 2.03 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
AMBALALSA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
AMBALALSA Company Profile
Ambalal Sarabhai Enterprises Limited is a manufacturer of formulations. It markets specialty pharmaceutical products under its three sub-divisions: oncology, infertility and uro-gynaec.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.55%
2.55%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
—
—
AMBALALSA Sentiment Analysis
AMBALALSA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AMBALALSA Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
AMBALALSA Stock Growth Drivers
AMBALALSA Stock Growth Drivers
4Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
AMBALALSA Stock Challenges
AMBALALSA Stock Challenges
2Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
AMBALALSA Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
AMBALALSA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
AMBALALSA
AMBALALSA
Income
Balance Sheet
Cash Flow
Annual Normal View
AMBALALSA Income Statement
AMBALALSA Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 140.37 | 150.24 | 159.60 | 157.89 | 203.33 | 245.19 | 182.77 | 183.94 | 208.21 | 208.69 | ||||||||||
Raw Materials | 77.06 | 71.33 | 90.28 | 81.51 | 98.39 | 114.07 | 105.24 | 98.61 | 195.10 | 195.58 | ||||||||||
| Power & Fuel Cost | 2.68 | 2.84 | 3.22 | 2.71 | 2.86 | 3.64 | 4.20 | 5.48 | ||||||||||||
| Employee Cost | 28.71 | 26.67 | 26.02 | 27.06 | 28.17 | 25.27 | 22.05 | 24.59 | ||||||||||||
| Selling & Administrative Expenses | 18.98 | 18.35 | 18.34 | 17.15 | 19.14 | 16.67 | 19.62 | 20.70 | ||||||||||||
| Operating & Other expenses | 17.52 | 17.56 | 8.13 | 8.35 | 16.63 | 26.98 | 11.02 | 18.24 | ||||||||||||
EBITDA | -4.58 | 13.49 | 13.61 | 21.11 | 38.14 | 58.56 | 20.64 | 16.32 | 13.11 | 13.11 | ||||||||||
| Depreciation/Amortization | 4.27 | 2.12 | 2.10 | 2.57 | 2.41 | 2.32 | 2.76 | 3.57 | 4.01 | 4.00 | ||||||||||
| PBIT | -8.85 | 11.37 | 11.51 | 18.54 | 35.73 | 56.24 | 17.88 | 12.75 | 9.10 | 9.11 | ||||||||||
| Interest & Other Items | 4.77 | 3.41 | 3.29 | 3.61 | 3.20 | 2.04 | 2.71 | 6.09 | 4.26 | 4.27 | ||||||||||
| PBT | -13.62 | 7.96 | 8.22 | 14.93 | 32.53 | 54.20 | 15.17 | 6.66 | 4.84 | 4.84 | ||||||||||
| Taxes & Other Items | 4.60 | 6.69 | 3.97 | 0.88 | 3.18 | 6.98 | 3.72 | 0.98 | -0.09 | -0.09 | ||||||||||
| Net Income | -18.22 | 1.27 | 4.25 | 14.05 | 29.35 | 47.22 | 11.45 | 5.68 | 4.93 | 4.93 | ||||||||||
| EPS | -2.38 | 0.17 | 0.55 | 1.83 | 3.83 | 6.16 | 1.49 | 0.74 | 0.64 | 0.64 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
AMBALALSA Company Updates
AMBALALSA Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
AMBALALSA Past Performance & Peer Comparison
AMBALALSA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ambalal Sarabhai Enterprises Ltd | 56.44 | 2.03 | — |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
AMBALALSA Stock Price Comparison
Compare AMBALALSA with any stock or ETFCompare AMBALALSA with any stock or ETF
AMBALALSA
AMBALALSA Holdings
AMBALALSA Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
AMBALALSA Promoter Holdings Trend
AMBALALSA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AMBALALSA Institutional Holdings Trend
AMBALALSA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMBALALSA Shareholding Pattern
AMBALALSA Shareholding Pattern
AMBALALSA Shareholding History
AMBALALSA Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing AMBALALSA stock
smallcases containing AMBALALSA stock
Looks like this stock is not in any smallcase yet.
AMBALALSA Events
AMBALALSA Events
AMBALALSA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMBALALSA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
AMBALALSA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMBALALSA has not given any dividends in last 5 years
AMBALALSA Dividends
AMBALALSA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAMBALALSA Stock News & Opinions
AMBALALSA Stock News & Opinions
Articles & Videos
Corporate
Ambalal Sarabhai Enterprises schedules AGM
Ambalal Sarabhai Enterprises announced that the 47th Annual General Meeting(AGM) of the company will be held on 17 July 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Earnings
Ambalal Sarabhai Enterprises reports consolidated net loss of Rs 0.27 crore in the March 2025 quarter
Net loss of Ambalal Sarabhai Enterprises reported to Rs 0.27 crore in the quarter ended March 2025 as against net profit of Rs 9.02 crore during the previous quarter ended March 2024. Sales rose 19.25% to Rs 64.81 crore in the quarter ended March 2025 as against Rs 54.35 crore during the previous quarter ended March 2024. For the full year,net profit declined 13.20% to Rs 4.93 crore in the year ended March 2025 as against Rs 5.68 crore during the previous year ended March 2024. Sales rose 13.03% to Rs 196.19 crore in the year ended March 2025 as against Rs 173.57 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales64.8154.35 19 196.19173.57 13 OPM %8.188.56 -4.122.08 - PBDT5.978.54 -30 15.8410.23 55 PBT4.958.29 -40 11.836.65 78 NP-0.279.02 PL 4.935.68 -13 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Ambalal Sarabhai Enterprises to table results
Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Ambalal Sarabhai Enterprises consolidated net profit rises 67.67% in the December 2024 quarter
Net profit of Ambalal Sarabhai Enterprises rose 67.67% to Rs 2.23 crore in the quarter ended December 2024 as against Rs 1.33 crore during the previous quarter ended December 2023. Sales rose 6.63% to Rs 45.97 crore in the quarter ended December 2024 as against Rs 43.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales45.9743.11 7 OPM %-1.525.87 - PBDT3.923.17 24 PBT2.932.03 44 NP2.231.33 68 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Ambalal Sarabhai Enterprises to convene board meeting
Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Ambalal Sarabhai Enterprises consolidated net profit rises 142.59% in the September 2024 quarter
Net profit of Ambalal Sarabhai Enterprises rose 142.59% to Rs 2.62 crore in the quarter ended September 2024 as against Rs 1.08 crore during the previous quarter ended September 2023. Sales rose 11.72% to Rs 44.70 crore in the quarter ended September 2024 as against Rs 40.01 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales44.7040.01 12 OPM %5.682.55 - PBDT4.122.94 40 PBT3.111.81 72 NP2.621.08 143 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Ambalal Sarabhai Enterprises to convene board meeting
Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Ambalal Sarabhai Enterprises reports consolidated net profit of Rs 0.35 crore in the June 2024 quarter
Net profit of Ambalal Sarabhai Enterprises reported to Rs 0.35 crore in the quarter ended June 2024 as against net loss of Rs 4.87 crore during the previous quarter ended June 2023. Sales rose 12.74% to Rs 40.70 crore in the quarter ended June 2024 as against Rs 36.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales40.7036.10 13 OPM %1.18-11.00 - PBDT1.82-3.55 LP PBT0.84-4.60 LP NP0.35-4.87 LP Powered by Capital Market - Live
10 months agoCapital Market - Live
Ambalal Sarabhai Enterprises consolidated net profit declines 14.00% in the December 2022 quarter
2 years agoBusiness Standard
Ambalal Sarabhai Enterprises consolidated net profit rises 73.27% in the December 2021 quarter
3 years agoBusiness Standard
Over the last 5 years, revenue has grown at a yearly rate of 2.88%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0.04% to 0.05%
Over the last 5 years, net income has grown at a yearly rate of 5.97%, vs industry avg of 15.29%